Cystic fibrosis fransmembrane regulator modulator therapies effect on liver function in Bulgarian patients

Conclusion: We did not identify worsening in the liver status after CFTRm therapy with CTFRm. The results of the study suggest an improvement of liver function after initiation of IVA/LUM. As a limitation of our study there are not patients with very advanced liver cirrhosis included on CFTRm therapy.

Source: European Respiratory Journal - October 27, 2023 Category: Respiratory Medicine Authors: Petkova, D., Baycheva, M., Petkova, V., Papochieva, V., Genkova, K., Andonova, Y., Nikolov, I., Shahid, P., Miteva, D., Petrova, G. Tags: Paediatric cystic fibrosis (CF) Source Type: research